Jae Weon Kim

No ORCID on file · 9 papers in corpus
other 2022
In vivo (Athens, Greece) ·doi:10.21873/invivo.12693

BACKGROUND/AIM: To investigate the role of the expression of hypoxia-related genes on the prognosis of ovarian clear cell carcinoma (OCCC). MATERIALS AND METHODS: Basal mRNA levels of eight hypoxia-related genes were compared. Cell viabili…

observational 2018
BMC cancer ·doi:10.1186/s12885-018-4498-z

BACKGROUND: The survival of patients with ovarian cancer has improved because of surgery and chemotherapy. This study aimed to estimate the changes in survival rates among Korean women with ovarian cancer prior to the introduction of target…

other 2015
Obstetrics & Gynecology Science ·doi:10.5468/ogs.2015.58.2.98

OBJECTIVE: Despite the good prognosis of borderline ovarian tumors (BOTs), a few BOT patients experience the relapse of disease, either borderline or malignant. However, the risk of recurrence of BOTs is somewhat controversial. We intended …

review 2012
Journal of gynecologic oncology ·doi:10.3802/jgo.2012.23.1.53

The annual review of 2011 comprised 11 themes of major research achievements in gynecologic oncology including breast cancer. A potential paradigm shift in the management of ovarian cancer was reviewed through comprehensive genomic analyses…

other 2012
Gynecologic Oncology ·doi:10.1016/j.ygyno.2012.12.037

OBJECTIVE: To analyze the outcomes of second round of fertility-sparing management using progestin in patients with recurrent endometrial cancer after successful fertility-sparing management using progestin. METHODS: We reviewed 45 patient…

other 2010
Journal of gynecologic oncology ·doi:10.3802/jgo.2010.21.3.137

This workshop was held on July 31-August 1, 2010 and was organized to promote the academic environment and to enhance the communication among Asian countries prior to the 2nd biennial meeting of Australian Society of Gynaecologic Oncologist…

review 2010
Journal of gynecologic oncology ·doi:10.3802/jgo.2010.21.4.209

This review summarizes 11 major clinical research advances in gynecologic oncology in 2010. For ovarian cancer, bevacizumab as a leading molecular targeted agent, pegylated liposomal doxorubicin in recurrent disease, the role of neoadjuvant…

rct 2009
Trials ·doi:10.1186/1745-6215-10-8

BACKGROUND: Laparoscopy-assisted vaginal hysterectomy is one of the definite methods for the treatment of symptomatic uterine fibroids with lesser intraoperative bleeding and shorter hospitalization compared with abdominal hysterectomy. How…

case-report 2005
Gynecologic Oncology ·doi:10.1016/j.ygyno.2005.01.043

BACKGROUND: Choriocarcinoma of the fallopian tube is extremely rare as is choriocarcinoma with a viable pregnancy. We present an unusual case of prima gravida at 33 weeks gestation that was diagnosed as having tubal choriocarcinoma which wa…